Bioelectric Medicine Market Opportunity Analysis, 2018-2026

Bioelectric medicine is a new and innovative approach to diagnose and treat injuries and diseases. All major organs of the body are connected to the nerves, which allows the brain to monitor and regulate the functions of the organs. Bioelectric medicine refers to the usage of a device to modulate and read the electrical activity within the body’s nervous systems. Nerve blocking devices or nerve stimulating devices that are held against the skin or implanted on a nerve have the potential to regulate specific nerve activity, make specific changes in organ function, and also restore health, without much complicated side effects of pharmaceutical agents. Bioelectric medicine technology is used to record, block, and stimulate neural signals to change the way diseases and injuries are treated. It is also used for the treatment of conditions such as cancer, paralysis, rheumatoid arthritis, and diabetes. Electroceuticals are alternatives to drug based remedies.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1757

Bioelectric Medicine Market Drivers:

Mergers and acquisitions, advancements in technology, and innovations such as non-invasive devices in the field of bioelectric medicines are the major factors driving growth of the bioelectric medicine market. For instance, in 2016, GlaxoSmithKline Plc. (GSK) merged with Google’s parent company Alphabet to set up a new bioelectric company called Galvani Bioelectronics, which will benefit over 2 billion people who are suffering from chronic diseases. GSK invested around US$ 615 million for the development of Galvani Bioelectronics. In 2015, Synapse Electroceutical Technology, a UK-based company launched a new product Accel-Heal, which is a non-invasive class 2A medical device. The device also promotes healing of leg ulcers by using electrical energy. Accel-Heal delivers a sequence of low level, pre-programmed and sub sensory electrical energy through surface of the skin. Synapse Electroceutical Technology has a product for venous leg ulcer management in the pipeline, which is expected to fuel growth of the bioelectric medicine market over the forecast period. Other factors that boost growth of the bioelectric medicine market include increasing number of diseases in geriatric population such as cardiac arrhythmias, Parkinson’s disease, Alzheimer’s disease, epilepsy, and depression, and rise in chronic diseases such as neurological and cardiac disorders. According to a study conducted by Journal of Family Medicine and Primary Care in 2017, four major chronic diseases including cancer, cardiovascular disease, diabetes, and chronic respiratory diseases were the major cause for 82% deaths in India. According to a study conducted by World Health Organization (WHO) in 2017, non-communicable diseases are expected to contribute to death of 52 million people by 2030 globally.

However, high cost of devices and lack of skilled technicians to use these devices are expected to hamper growth of the bioelectric medicine market.

Bioelectric Medicine Market Regional Analysis:

Europe is expected to witness significant growth in the global bioelectric medicine market due to mergers and acquisitions and advancements in R&D. For instance, in 2015, GSK had over 50 research collaborations in the field of bioelectric medicine. In 2013, GSK invested in a start-up company called Set Point, who is involved in the development of implantable devices that would stimulate the vagus nerve in the neck with electrical impulses. North America is also expected to witness significant growth in the bioelectric medicine market due to advancements in research and development.

For instance, Electro Core, a U.S.-based company is working on a device to treat headaches related to migraines by stimulating vagus nerve on the neck with electrical impulses. In 2017, Reshape Lifesciences launched minimally invasive medical devices ReShape Balloon, ReShape VBloc, and ReShape Vest to treat obesity and metabolic diseases. In 2014, the U.S. FDA approved Inspire Medical Systems’ Sleep Apnea Treatment to treat sleep apnea by implanting a device that stimulates air way muscles. Asia Pacific is also expected to exhibit significant growth in the bioelectric medicine market, owing to the rising number of people diagnosed with chronic diseases. According to a survey conducted by the National Health and Family Planning Commission (NHFPC) in 2017, prevalence of hypertension in adults in China was 25.2% and diabetes was 9.7%.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1757

Bioelectric Medicine Market Key Players:

Key players operating in the global bioelectric medicine market include Medtronic PLC, Sonava, Boston Scientific Corporation, St Jude Medical, Liva Nova PLC, Biotronic, Second Sight Medical Products, Nevro Corp, and Electrocare among others.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.